Home > Financial Ratios > DR LAL PATHLABS

DR LAL PATHLABS
EV/Core EBITDA

    Back to All Ratios
DR LAL PATHLABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for DR LAL PATHLABS
Please provide your vote to see the results

DR LAL PATHLABS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 26.7427.8634.9944.3827.87

What is the latest EV/Core EBITDA ratio of DR LAL PATHLABS ?

The latest EV/Core EBITDA ratio of DR LAL PATHLABS is 26.74 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202426.74
Mar202327.86
Mar202234.99
Mar202144.38
Mar202027.87

How is EV/Core EBITDA of DR LAL PATHLABS Trending?

Years EV/Core EBITDA % Change
Mar2024 26.74
-4.02
Mar2023 27.86
-20.38
Mar2022 34.99
-21.16
Mar2021 44.38
59.24
Mar2020 27.87 -

Other Financial Ratios of DR LAL PATHLABS


Compare EV/Core EBITDA ratio of peers of DR LAL PATHLABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR LAL PATHLABS ₹23,420.1 Cr -2.1% -6.8% 11% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹109,395.0 Cr 1.7% -7% 42.8% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹98,797.3 Cr 0.5% -3.1% 12.1% Stock Analytics
FORTIS HEALTHCARE ₹49,151.6 Cr 3.8% -8.8% 47.4% Stock Analytics
GLOBAL HEALTH ₹31,387.1 Cr 9% 9.3% -6.7% Stock Analytics
NARAYANA HRUDAYALAYA ₹28,052.6 Cr 1.6% 3.2% -0.6% Stock Analytics


DR LAL PATHLABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR LAL PATHLABS

-2.1%

-6.8%

11%

SENSEX

0.7%

-0.1%

8.8%


You may also like the below Video Courses